In short
This article examines clinical trials investigating the use of Salbutamol Sulfate Ph. Eur. in patients with severe eosinophilic asthma. Salbutamol Sulfate, also known as albuterol, is a short-acting beta-2 agonist commonly used as a rescue inhaler for asthma symptoms. The trials aim to assess its efficacy and safety when used alongside other asthma medications in patients with this severe form of asthma characterized by high levels of eosinophils, a type of white blood cell.
At a glance
- Study Type
- Randomized, double-blind, placebo-controlled, parallel-group
- Primary Objective
- Assess efficacy of dexpramipexole in reducing severe asthma exacerbations
- Secondary Objectives
- Evaluate effects on pulmonary function, asthma control, quality of life, and blood eosinophils
- Participant Criteria
- Age ≥12 years (≥18 in EU), diagnosed asthma for ≥12 months, high eosinophil count, history of exacerbations
- Treatment Duration
- 52 weeks of treatment + 4 weeks follow-up
- Salbutamol Sulfate Role
- Used as rescue medication throughout the study
- Primary Endpoint
- Annualized rate of severe asthma exacerbations over 52 weeks
- Key Secondary Endpoints
- Changes in FEV1, ACQ-6 scores, and AQLQ+12 scores
What is Salbutamol Sulfate?
Salbutamol Sulfate, also known as Albuterol Sulfate, is a medication primarily used to treat asthma and other respiratory conditions. It belongs to a class of drugs called short-acting beta-2 agonists (SABAs). In the context of severe eosinophilic asthma, Salbutamol Sulfate plays a crucial role in managing symptoms and improving lung function.
How Does It Work?
Salbutamol Sulfate works by relaxing the smooth muscles in the airways, which leads to bronchodilation - the widening of the bronchi and bronchioles in the lungs. This action helps to relieve bronchospasm, reduce wheezing, and improve breathing in patients with asthma. The medication specifically targets beta-2 receptors in the lungs, providing quick relief from asthma symptoms.
Uses and Benefits
The primary uses and benefits of Salbutamol Sulfate in severe eosinophilic asthma include:
- Quick relief of asthma symptoms such as wheezing, shortness of breath, and chest tightness
- Prevention of exercise-induced bronchospasm
- Use as a rescue medication during asthma attacks
- Improvement in lung function, as measured by FEV1 (Forced Expiratory Volume in 1 second)
In clinical trials, Salbutamol Sulfate has been used as a standard medication to assess bronchodilator reversibility, which is an important criterion for diagnosing and evaluating asthma.
Administration
Salbutamol Sulfate is typically administered through inhalation. The specific product mentioned in the clinical trials is "Sultanol Dosier-Aerosol 100 Mikrogramm/Dosis Druckgasinhalation, Suspension," which is a pressurized inhalation suspension. This form of administration allows the medication to be delivered directly to the lungs, where it can act quickly to relieve asthma symptoms.
The typical dosage used in clinical trials for assessing bronchodilator reversibility is 400 μg (micrograms), which is usually administered as four puffs of 100 μg each. However, the exact dosage may vary depending on individual patient needs and should be determined by a healthcare professional.
Potential Side Effects
While Salbutamol Sulfate is generally well-tolerated, it may cause some side effects. Common side effects may include:
- Tremors
- Nervousness
- Headache
- Rapid heartbeat
- Throat irritation
It's important to discuss any side effects with your healthcare provider.
Precautions and Considerations
When using Salbutamol Sulfate, patients should be aware of the following:
- Overuse of short-acting beta-2 agonists like Salbutamol Sulfate can lead to decreased effectiveness over time
- Patients with certain heart conditions should use this medication with caution
- It's important to follow the prescribed dosage and not exceed the recommended amount
- Inform your doctor if you're pregnant, planning to become pregnant, or breastfeeding
Ongoing Research
While Salbutamol Sulfate is an established medication for asthma treatment, ongoing research continues to explore its role in severe eosinophilic asthma. In recent clinical trials, such as the EXHALE-3 study, Salbutamol Sulfate has been used as a standard medication to assess lung function and bronchodilator reversibility in patients with severe eosinophilic asthma.
These studies aim to better understand the effectiveness of new treatments for severe eosinophilic asthma by comparing them to established medications like Salbutamol Sulfate. This ongoing research helps to improve our understanding of asthma management and may lead to more effective treatment strategies in the future.